# Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions

> **NCT02981355** · PHASE4 · TERMINATED · sponsor: **Piramal Healthcare Canada Ltd** · enrollment: 5 (actual)

## Conditions studied

- Traumatic; Lesion
- Degenerative Lesion of Articular Cartilage of Knee

## Interventions

- **PROCEDURE:** Microfracture treatment
- **DEVICE:** BST-CarGel

## Key facts

- **NCT ID:** NCT02981355
- **Lead sponsor:** Piramal Healthcare Canada Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-26
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-03-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2018-11-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981355, "Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02981355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*